Credit Suisse Initiates Coverage On Mosaic, Sees Notable Upside
Credit Suisse analyst John Roberts initiated coverage of Mosaic Co (NYSE:MOS) with an Outperform rating and a price target of $60, implying an…
SVB Likes This ‘Novel Antipsychotic’-Focused Stock
SVB Leerink initiated coverage on Karuna Therapeutics Inc (NASDAQ:KRTX) with an Outperform rating and a price target of $170. SVB notes that…
RBC Capital Cuts Boeing Price Target By 9%
RBC Capital analyst Ken Herbert lowered the price target on Boeing Co (NYSE:BA) to $200 (39% upside) from $220 while maintaining the Outperform…
Goldman Sachs Maintains Buy on WalkMe, Lowers Price Target to $14
Goldman Sachs maintains WalkMe (NASDAQ:WKME) with a Buy and lowers the price target from $18 to $14.
Goldman Sachs Maintains Sell on Riskified, Lowers Price Target to $4.5
Goldman Sachs analyst Will Nance maintains Riskified (NYSE:RSKD) with a Sell and lowers the price target from $6 to $4.5.
Why This AMD Analyst Is Turning Bullish
Advanced Micro Devices Inc. (NASDAQ: AMD) exhibits "continued superior execution on all fronts," according to BMO Capital Markets.
Goldman Sachs Maintains Neutral on PerkinElmer, Lowers Price Target to $175
Goldman Sachs analyst Matthew Sykes maintains PerkinElmer (NYSE:PKI) with a Neutral and lowers the price target from $200 to $175.
Goldman Sachs Maintains Neutral on PagSeguro Digital, Lowers Price Target to $13
Goldman Sachs analyst Tito Labarta maintains PagSeguro Digital (NYSE:PAGS) with a Neutral and lowers the price target from $19 to $13.
Goldman Sachs Maintains Neutral on Olink Holding, Lowers Price Target to $16
Goldman Sachs analyst Matthew Sykes maintains Olink Holding (NASDAQ:OLK) with a Neutral and lowers the price target from $20 to $16.
Goldman Sachs Maintains Buy on Maravai LifeSciences, Lowers Price Target to $35
Goldman Sachs maintains Maravai LifeSciences (NASDAQ:MRVI) with a Buy and lowers the price target from $44 to $35.